Vice President - Portfolio Strategy & Pipeline

Facility:
Commercial Marketing

Location:

Plainsboro, NJ, US

About the Department
Our Marketing Patients & Solutions group creates and delivers human-centered experiences, where innovation meets customer-centricity, driving the ultimate experience for our patients. Our focus extends beyond transactions to craft experiences as one fully integrated, aligned, and connected organization that puts empathy at the center, powered by insight and foresight.

We prioritize customer and patient experience through agile implementation and omnichannel orchestration, ensuring that every touchpoint is managed effectively for maximum engagement. Our team develops integrated, next-gen customer engagement strategies that enhance marketing and experience operations while operationalizing pharmacy solutions to improve patient services.

We employ an end-to-end approach to strategy, utilizing integrated actionable insights to inform our decision-making. This ensures our strategies are rooted in a deep understanding of customer needs and behaviors, enabling the identification of new opportunities. Our 'test and learn' mindset empowers us to iterate rapidly and refine our strategies based on real-world results.

We are building an intentional team culture comprised of diverse skill sets, united by the shared belief that reinvention and learning fuel continuous growth. Our focus on business planning, effective ways of working, and a project office environment enhances operational efficiency and drives success.

The Position

The Vice President, US Portfolio Strategy and Pipeline is responsible for and leads a team focused on the cardiometabolic portfolio strategy including developing clear, enterprise wide USO perspective on all cardiometabolic pipeline assets, early product management, opportunity and drug identification, early commercialization strategy, pipeline strategy and product transition.

Establish the US portfolio strategy to drive the future growth of the Novo Nordisk cardiometabolic portfolio which includes diabetes, obesity, cardiovascular diseases, and future therapeutic areas/disease states. Steer the global cardiometabolic portfolio strategy to implement an integrated long-term plan reflecting the needs of the US market to enhance patient therapy outcomes, maximize portfolio revenue, grow market share, and meet business profitability goals.

Partner with Rare Disease to ensure clear USO prioritization and trade-offs as it relates to cross disease area decision making.

Facilitate the development of a customer centric, enterprise-wide strategy for new therapy areas, including market development and go-to-market considerations, pipeline products development focusing on a time horizon of 18 months from commercialization and partner with Global on BD&L opportunities relevant to the US business.

Support the transition to internal stakeholders to ensure operationalization of the commercialization of new assets and maximization of US entry in those new therapeutic areas.

Relationships

Reports to SVP, Marketing & Patient Solutions. The VP, Portfolio Strategy & Pipeline is a member of US Marketing & Patient Solutions leadership team, and represents the portfolio plans in management discussions. Interacts and aligns CMR, Business Development, Market Access, Finance, Enterprise Strategy and relevant global Commercial and Development teams to develop clear US perspectives. Represents the US portfolio position to facilitate decision making on US and global BD&L committees.

Essential Functions

• Integrated Portfolio Strategy:
  Recommend strategic trade-offs on resource allocation and budgeting across portfolio.
• Own commercial input for Business Development and Licensing committees.
• Pipeline Strategy:
  Develop, communicate, and update the Comprehensive US enterprise – wide perspective on pipeline assets inclusive of trade-off consideration. Effectively analyze and assess new disease areas. Determine and own early product resource allocation decisions and investments. Provide pipeline strategy and pre-launch access inputs in collaboration with US cross-functional. Conduct annual plans for early products and provide portfolio and pipeline prioritization recommendations.
• Early Product Management:
  Establish the early commercialization strategy for new assets. Lead early product component of lifecycle management strategy. Proactively align with relevant functional partners.
• Product Transition:
  Make recommendations regarding all asset transitions and the timeline.
• BD&L…